【摘要】慢性肾脏病-矿物质和骨代谢异常(chronic kidney disease-mineral and bone disorder，CKD-MBD)是慢性肾脏病(chronic kidney disease，CKD)患者常见的并发症之一，控制高磷血症为防治CKD-MBD 的关键。然而，药物作为慢性肾脏病患者磷肠道负荷的潜在来源却常常被忽视。故本文针对药物的磷含量、低磷/蛋白质比值饮食的研究进展予以综述。

【Abstract】Chronic kidney disease-mineral and bone disorder (CKD-MBD) is one of the common complications in patients with chronic kidney disease (CKD), and the control of hyperphosphatemia is the key to the prevention and treatment of CKD- MBD. However, drugs are often overlooked as the potential sources of phosphorus burden in patients with chronic kidney disease. Therefore, the research progresses in phosphate content of drugs, low dietary phosphorus to protein ratio are reviewed in this article.